LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.240
-0.040 (-3.13%)
May 5, 2025, 4:00 PM EDT - Market closed
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $32.62 million as of May 6, 2025. Its market cap has decreased by -57.80% in one year.
Market Cap
32.62M
Enterprise Value
-38.68M
1-Year Change
-57.80%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $32.62M, a decrease of -91.42%. That is a compound annual growth rate of -45.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 33.67M | 34.63% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |